205 related articles for article (PubMed ID: 35964057)
1. Sourcing of human peripheral blood-derived myeloid angiogenic cells under xeno-free conditions for the treatment of critical limb ischemia.
Wong CWT; Sawhney A; Wu Y; Mak YW; Tian XY; Chan HF; Blocki A
Stem Cell Res Ther; 2022 Aug; 13(1):419. PubMed ID: 35964057
[TBL] [Abstract][Full Text] [Related]
2. Sourcing of an alternative pericyte-like cell type from peripheral blood in clinically relevant numbers for therapeutic angiogenic applications.
Blocki A; Wang Y; Koch M; Goralczyk A; Beyer S; Agarwal N; Lee M; Moonshi S; Dewavrin JY; Peh P; Schwarz H; Bhakoo K; Raghunath M
Mol Ther; 2015 Mar; 23(3):510-22. PubMed ID: 25582709
[TBL] [Abstract][Full Text] [Related]
3. The controversial origin of pericytes during angiogenesis - Implications for cell-based therapeutic angiogenesis and cell-based therapies.
Blocki A; Beyer S; Jung F; Raghunath M
Clin Hemorheol Microcirc; 2018; 69(1-2):215-232. PubMed ID: 29758937
[TBL] [Abstract][Full Text] [Related]
4. Expansion and angiogenic potential of mesenchymal stem cells from patients with critical limb ischemia.
Brewster L; Robinson S; Wang R; Griffiths S; Li H; Peister A; Copland I; McDevitt T
J Vasc Surg; 2017 Mar; 65(3):826-838.e1. PubMed ID: 26921003
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of mouse bone marrow and adipose tissue mesenchymal stem cells for critical limb ischemia cell therapy.
Nammian P; Asadi-Yousefabad SL; Daneshi S; Sheikhha MH; Tabei SMB; Razban V
Stem Cell Res Ther; 2021 Jan; 12(1):58. PubMed ID: 33436054
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis in diabetic mouse model with critical limb ischemia; cell and gene therapy.
Asadi-Yousefabad SL; Nammian P; Tabei SMB; Daneshi S; Fallahi J; Razban V; Sheikhha MH
Microvasc Res; 2022 May; 141():104339. PubMed ID: 35151721
[TBL] [Abstract][Full Text] [Related]
7. Angiogenic effects of cell therapy within a biomaterial scaffold in a rat hind limb ischemia model.
Amani S; Shahrooz R; Hobbenaghi R; Mohammadi R; Baradar Khoshfetrat A; Karimi A; Bakhtiari Z; Adcock IM; Mortaz E
Sci Rep; 2021 Oct; 11(1):20545. PubMed ID: 34654868
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic angiogenesis using zinc oxide nanoflowers for the treatment of hind limb ischemia in a rat model.
Barui AK; Nethi SK; Basuthakur P; Jhelum P; Bollu VS; Reddy BR; Chakravarty S; Patra CR
Biomed Mater; 2021 Mar; 16(4):. PubMed ID: 33657534
[TBL] [Abstract][Full Text] [Related]
9. Report of a phase 1 clinical trial for safety assessment of human placental mesenchymal stem cells therapy in patients with critical limb ischemia (CLI).
Shirbaghaee Z; Heidari Keshel S; Rasouli M; Valizadeh M; Hashemi Nazari SS; Hassani M; Soleimani M
Stem Cell Res Ther; 2023 Jul; 14(1):174. PubMed ID: 37408043
[TBL] [Abstract][Full Text] [Related]
10. In vivo efficacy of endothelial growth medium stimulated mesenchymal stem cells derived from patients with critical limb ischemia.
Al-Rifai R; Nguyen P; Bouland N; Terryn C; Kanagaratnam L; Poitevin G; François C; Boisson-Vidal C; Sevestre MA; Tournois C
J Transl Med; 2019 Aug; 17(1):261. PubMed ID: 31399109
[TBL] [Abstract][Full Text] [Related]
11. Self-assembled GFFYK peptide hydrogel enhances the therapeutic efficacy of mesenchymal stem cells in a mouse hindlimb ischemia model.
Huang A; Liu D; Qi X; Yue Z; Cao H; Zhang K; Lei X; Wang Y; Kong D; Gao J; Li Z; Liu N; Wang Y
Acta Biomater; 2019 Feb; 85():94-105. PubMed ID: 30550934
[TBL] [Abstract][Full Text] [Related]
12. Neovascularization capacity of mesenchymal stromal cells from critical limb ischemia patients is equivalent to healthy controls.
Gremmels H; Teraa M; Quax PH; den Ouden K; Fledderus JO; Verhaar MC
Mol Ther; 2014 Nov; 22(11):1960-70. PubMed ID: 25174586
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic transplantation of programmable cells of monocytic origin (PCMO) improves angiogenesis and tissue recovery in critical limb ischemia (CLI): a translational approach.
Berndt R; Hummitzsch L; Heß K; Albrecht M; Zitta K; Rusch R; Sarras B; Bayer A; Cremer J; Faendrich F; Groß J
Stem Cell Res Ther; 2018 Apr; 9(1):117. PubMed ID: 29703251
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the reparative and angiogenic properties of mesenchymal stem cells derived from the bone marrow of BALB/c and C57/BL6 mice in a model of limb ischemia.
Cunha FF; Martins L; Martin PK; Stilhano RS; Han SW
Stem Cell Res Ther; 2013 Jul; 4(4):86. PubMed ID: 23890057
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-α-activated mesenchymal stem cells promote endothelial progenitor cell homing and angiogenesis.
Kwon YW; Heo SC; Jeong GO; Yoon JW; Mo WM; Lee MJ; Jang IH; Kwon SM; Lee JS; Kim JH
Biochim Biophys Acta; 2013 Dec; 1832(12):2136-44. PubMed ID: 23959047
[TBL] [Abstract][Full Text] [Related]
16. Fasudil, a ROCK inhibitor, preserves limb integrity in a mouse model of unilateral critical limb ischemia: Possible interplay of inflammatory and angiogenic signaling pathways.
El-Waseif AG; Nader MA; Salem HA; Elshaer SL
Life Sci; 2022 Nov; 309():121019. PubMed ID: 36195296
[TBL] [Abstract][Full Text] [Related]
17. Human Umbilical Cord-Derived Mesenchymal Stem Cells Relieve Hind Limb Ischemia by Promoting Angiogenesis in Mice.
Wang Z; Zheng L; Lian C; Qi Y; Li W; Wang S
Stem Cells Dev; 2019 Oct; 28(20):1384-1397. PubMed ID: 31407635
[TBL] [Abstract][Full Text] [Related]
18. Assessing Therapeutic Angiogenesis in a Murine Model of Hindlimb Ischemia.
Ministro A; de Oliveira P; Nunes RJ; Dos Santos Rocha A; Ferreira T; Goyri-O'Neill J; Rosa Santos SC
J Vis Exp; 2019 Jun; (148):. PubMed ID: 31233022
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow mesenchymal stem cell-derived endothelial cells increase capillary density and accelerate angiogenesis in mouse hindlimb ischemia model.
Yao Z; Liu H; Yang M; Bai Y; Zhang B; Wang C; Yan Z; Niu G; Zou Y; Li Y
Stem Cell Res Ther; 2020 Jun; 11(1):221. PubMed ID: 32513272
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal Stromal Cells (MSCs): A Promising Tool for Cell-Based Angiogenic Therapy.
Ulpiano C; da Silva CL; Monteiro GA
Curr Gene Ther; 2021; 21(5):382-405. PubMed ID: 34533444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
